| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |